Sentence examples for narrow treatment from inspiring English sources

Ischemic stroke is currently treated with thrombolytic therapy with the drawback that it induces hemorrhagic transformation (HT) if applied beyond its relatively narrow treatment time window.

Pre-existing anticoagulant drugs, such as unfractionated heparin, low molecular weight heparin, warfarin, have some limitations: narrow treatment window, slow onset, causing bleeding [7, 8, 9, 10, 11, 12].

One solution is to cut Medicare and other health care benefits, to narrow treatment options, to slow the growth in benefits somewhat for wealthier recipients.

We suggest that when growth of organisms is inhibited by prior antibiotic treatment, particularly when Gram stain suggests non-viable organisms are present, molecular testing such as PCR/ESI-MS may provide an opportunity to narrow treatment.

Faster preliminary reports from the microbiology laboratories could not only help when empirical treatment fails, but also serve to narrow treatment when the preliminary report supports the clinical picture.

3– 9 Discordance in past research may partly be explained by relatively small study samples, narrow treatment inclusion criteria (eg, surgically treated patients), varying disease inclusion criteria with respect to tumor histology and stage, and limited geographic or population coverage.

Neither amorphous phases nor MCM-41-like materials were detected after the mesopore narrowing treatment.

As it is unclear ex ante how near- or far-sighted individuals are with respect to such changes, we also examine a narrower treatment group, looking only at those who were immediately affected, i.e. 16 23 in the years 1990 1991 (born 1967 1975), comparing them with the same control group as above.

Furthermore, such plasmids typically carry resistance genes to other drugs such as the aminoglycosides, thus narrowing treatment options.

Similarly, when a patient's condition improved ("doing better"), several residents indicated that family meetings were postponed or not planned as teams narrowed treatment efforts toward sustaining physiologic gains.

The second aim involves stopping therapy when the probability of infection is low, focusing and narrowing treatment once the microorganism is known, switching to monotherapy after day 3 whenever possible, and shortening treatment to 7 to 8 days for most patients, based on the clinical response and bacteriology findings.